Agios Pharmaceuticals: Q1 Earnings Insights

Comments
Loading...

 

Agios Pharmaceuticals AGIO reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Agios Pharmaceuticals beat estimated earnings by 3.87%, reporting an EPS of $-1.74 versus an estimate of $-1.81.

Revenue was up $832.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05 which was followed by a 5.7% increase in the share price the next day.

Here's a look at Agios Pharmaceuticals's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -1.69 -1.59 -1.41 -1.32
EPS Actual -1.74 -1.56 -1.44 -1.31
Revenue Estimate 560.00K 2.60M 2.48M 44.60M
Revenue Actual 0 0 0 0

To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Overview Rating:
Good
75%
Technicals Analysis
66
0100
Financials Analysis
80
0100
Overview
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!